MAPK7 and lung adenocarcinoma: Finally, copy number gain or amplification of ERK5, corresponding to higher mRNA expression of the ERK5 gene, has been reported in 18.9% and 13.5% of lung adenocarcinomas (LUAD) and lung squamous carcinomas (LUSC), respectively [39].